A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma
- 31 March 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (2-3) , 443-446
- https://doi.org/10.1016/s0959-8049(05)80073-5
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- A multicenter trial of interleukin-2 and low-dose cyclophosphamide in highly chemotherapy-resistant malignanciesCancer Treatment Reviews, 1989
- Combining Chemotherapy With Biological Response Modifiers in Treatment of CancerJNCI Journal of the National Cancer Institute, 1988
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987